Bowen Hanes & CO Inc Amgen Inc Transaction History

Bowen Hanes & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $438,754 - $514,319	-2,632 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1.24 Million - $1.4 Million	-6,868 Reduced 72.29%	2,632 $500,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.69 Million - $1.98 Million	9,500 New	9,500 $1.85 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Bowen Hanes & CO Inc with notifications on news.